These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 38790260)
1. Elucidating Cancer Subtypes by Using the Relationship between DNA Methylation and Gene Expression. Jilani M; Degras D; Haspel N Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790260 [TBL] [Abstract][Full Text] [Related]
2. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma. Pangeni RP; Zhang Z; Alvarez AA; Wan X; Sastry N; Lu S; Shi T; Huang T; Lei CX; James CD; Kessler JA; Brennan CW; Nakano I; Lu X; Hu B; Zhang W; Cheng SY Epigenetics; 2018; 13(4):432-448. PubMed ID: 29927689 [TBL] [Abstract][Full Text] [Related]
4. Identifying molecular subtypes in human colon cancer using gene expression and DNA methylation microarray data. Ren Z; Wang W; Li J Int J Oncol; 2016 Feb; 48(2):690-702. PubMed ID: 26647925 [TBL] [Abstract][Full Text] [Related]
5. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance. Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751 [No Abstract] [Full Text] [Related]
6. Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma. Park J; Shim JK; Yoon SJ; Kim SH; Chang JH; Kang SG Sci Rep; 2019 Jul; 9(1):10555. PubMed ID: 31332251 [TBL] [Abstract][Full Text] [Related]
7. Capturing the latent space of an Autoencoder for multi-omics integration and cancer subtyping. Madhumita ; Paul S Comput Biol Med; 2022 Sep; 148():105832. PubMed ID: 35834966 [TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma. Singh NP; Vinod PK Mol Genet Genomics; 2020 May; 295(3):807-824. PubMed ID: 32185457 [TBL] [Abstract][Full Text] [Related]
9. Multi-network approach to identify differentially methylated gene communities in cancer. R V; Nazeer KAA Gene; 2019 May; 697():227-237. PubMed ID: 30797996 [TBL] [Abstract][Full Text] [Related]
10. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression. Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962 [TBL] [Abstract][Full Text] [Related]
11. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma. Zhao Y; Gao Y; Xu X; Zhou J; Wang H BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346 [TBL] [Abstract][Full Text] [Related]
12. Subtype identification from heterogeneous TCGA datasets on a genomic scale by multi-view clustering with enhanced consensus. Cai M; Li L BMC Med Genomics; 2017 Dec; 10(Suppl 4):75. PubMed ID: 29322925 [TBL] [Abstract][Full Text] [Related]
13. A topological approach for cancer subtyping from gene expression data. Rafique O; Mir AH J Biomed Inform; 2020 Feb; 102():103357. PubMed ID: 31893527 [TBL] [Abstract][Full Text] [Related]
14. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma. Wang H; Wei C; Pan P; Yuan F; Cheng J Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305 [TBL] [Abstract][Full Text] [Related]
15. Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma. Zhang JX; Zhang J; Yan W; Wang YY; Han L; Yue X; Liu N; You YP; Jiang T; Pu PY; Kang CS Neuro Oncol; 2013 Mar; 15(3):279-89. PubMed ID: 23295773 [TBL] [Abstract][Full Text] [Related]
16. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data. El-Manzalawy Y; Hsieh TY; Shivakumar M; Kim D; Honavar V BMC Med Genomics; 2018 Sep; 11(Suppl 3):71. PubMed ID: 30255801 [TBL] [Abstract][Full Text] [Related]
17. Improving prediction performance of colon cancer prognosis based on the integration of clinical and multi-omics data. Tong D; Tian Y; Zhou T; Ye Q; Li J; Ding K; Li J BMC Med Inform Decis Mak; 2020 Feb; 20(1):22. PubMed ID: 32033604 [TBL] [Abstract][Full Text] [Related]
18. Improvement of cancer subtype prediction by incorporating transcriptome expression data and heterogeneous biological networks. Guo Y; Qi Y; Li Z; Shang X BMC Med Genomics; 2018 Dec; 11(Suppl 6):119. PubMed ID: 30598111 [TBL] [Abstract][Full Text] [Related]
19. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis. Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430 [TBL] [Abstract][Full Text] [Related]
20. RNA sequencing and Immunohistochemistry Reveal Esteve-Codina A; Alameda F; Carrato C; Pineda E; Arpí O; Martinez-García M; Mallo M; Gut M; Dabad M; Tortosa A; Del Barco S; Capellades J; Puig J; Gallego O; Pujol T; Oleaga L; Gil-Gil M; de Quintana-Schmidt C; Valduvieco I; Martinez-Cardús A; Bellosillo B; Muñoz-Marmol AM; Esteve A; Domenech M; Camins A; Craven-Bartle J; Villa S; Marruecos J; Domenech S; de la Iglesia N; Balana C Clin Cancer Res; 2021 Jan; 27(2):645-655. PubMed ID: 33106291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]